IP Library Granted Patent US 11,235,005
Granted Patent B2
US 11,235,005 · App. 15/964,784 · Granted Feb 1, 2022

Primed muscle progenitor cells and uses thereof

Inventor: Stacey L. Halum (Indianapolis, IN)
Assignee: Purdue Research Foundation
A61K35/34A61K35/30A61P21/00A61P25/00A61P43/00C12N5/0658A61K31/221A61K38/1883A61K2300/00C12N2501/805
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,235,005
App. No.
15/964,784
Granted
Feb 1, 2022
Kind
B2
Abstract

This invention relates to a method for repairing and reconstructing a damaged or non-functional muscle, in particular to a method and a tool kit using in vitro primed motor endplate-expressing muscle progenitor cells (MPCs) to promote innervation of the damaged or non-functional muscle using an agent without any genetic manipulation. This method is particularly useful for repairing or reconstructing damaged or non-functional head and neck muscles, and urinary detrusor bladder muscle.

Claims (12)

1. A method of cell therapy without any artificial supporting scaffolds for repairing or reconstructing a damaged or non-functioning muscle of a patient with enhanced innervation comprising the steps of:

a. acquiring a plurality of motor endplate-expressing muscle progenitor cells (MPCs) from a patient with a damaged muscle;

b. priming acquired MPCs by incubating said MPCs in the presence of an agent selected from the group consisting of acetylcholine, neuregulin, agrin, and a combination thereof; and

c. introducing the primed MPCs to the damaged muscle of said patient through minimally invasive, non-surgery injection directly to the site of damaged muscle.

2. The method of claim 1 , wherein said damaged or non-functioning muscle is denervated head or neck muscle.

3. The method of claim 1 , wherein said damaged or non-functioning muscle is a denervated laryngeal muscle.

4. The method of claim 1 , wherein said damaged or non-functioning muscle is a denervated muscle involved in swallowing or voicing.

5. The method of claim 1 , wherein MPCs are autologous-derived.

6. The method of claim 1 , wherein said damaged or non-functioning muscle is a denervated urinary detrusor bladder muscle.

7. The method of claim 1 , wherein said method provides a treatment for dysphagia.

8. The method of claim 1 , wherein said priming MPCs involves nogenetic manipulation and no artificial supporting scaffolds.

9. The method of claim 1 , wherein priming MPCs is carried out in vitro to induce the creation of connections between nerve neurons and muscle fibers by incubating in the presence of an agent and no artificial supporting scaffolds are involved in the process.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2018
From: HALUM, STACEY L.
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 045676/0983 →
Continuity (2)
Provisional Application 62490763 · Apr 27, 2017
Related Publication 20180311281A1 · Nov 1, 2018